期刊文献+

麝香保心丸治疗冠心病患者300例临床疗效观察 被引量:4

麝香保心丸治疗冠心病患者300例临床疗效观察
下载PDF
导出
摘要 目的:探讨麝香保心丸对冠心病患者的临床治疗效果。方法:将600例冠心病患者随机分为观察组和试验组,每组各300例,对观察组给予复方丹参滴丸,试验组给予麝香保心丸,连续治疗4个疗程后(28天),比较两组治疗前,治疗2个疗程后,4个疗程后的心电图和血脂变化等指标。结果:给药前观察组和试验组的心电图变化,血脂水平等方面比较,差异不存在统计学意义(P>0.05);给药2个疗程后(14天),上述指标与给药前比较,差异存在统计学意义(P<0.05),组间比较差异不具有统计学意义(P>0.05),连续给药4个疗程后(28天),上述指标与给药前比较,差异存在统计学意义(P<0.05),组间比较差异不具有统计学意义(P>0.05)。结论:麝香保心丸与复方丹参滴丸在调节血脂和改善心肌缺血治疗冠心病的临床疗效比较,均发挥基本等同的作用。 Objective:To discuss the efficacy of shexiang baoxin pills on coronary heart disease. Methods:600 cases coronary heart disease patients were randomly divided into observation group and experimental group. 300 cases in each group. The observation group were treated with Compound Danshen Dripping Pill. Experimental group were treated with shexiang baoxin pills. Two groups had 28 days treatmens. Two groups were compared in ECG and blood lipid changes, and other indicators, at different times. Resuits: There were no different at ECG and blood lipid before the theatment (P 〈 0. 05). After 14 days of treatment, ECG and blood lipid were better than befoure (P 〈 0. 05), but there were no different between two groups ( P 〉 0. 05 ). After 28 days of treatment, ECG and blood lipid were better than befoure ( P 〈 0. 05 ) , but there were no different between two groups ( P 〉 0. 05 ). Conclusion: Shexiang baoxin pills has the same effect on coronary heart disease with the Compound Danshen Dripping Pill. Shex- iang baoxin pills is worthy of widespread use in the treatment of coronary heart disease process.
作者 胡世贵
出处 《中国社区医师(医学专业)》 2012年第33期165-166,共2页
关键词 麝香保心丸 冠心病 治疗效果 Shexiang baoxin pills Coronary heart disease Treatment
  • 相关文献

参考文献5

二级参考文献44

共引文献284

同被引文献41

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部